Different checkpoints in human NK-cell activation

被引:114
作者
Moretta, L
Bottino, C
Pende, D
Vitale, M
Mingari, MC
Moretta, A
机构
[1] Ist Giannina Gaslini, I-16147 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[3] Univ Genoa, Ctr Eccellenza Ric Biomed, I-16132 Genoa, Italy
[4] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[5] Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy
关键词
D O I
10.1016/j.it.2004.09.008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
After the discovery, in humans and mice, of inhibitory natural killer (NK) receptors specific for MHC class I molecules, the mechanism by which NK cells kill tumor or virus-infected cells was thought to be clarified: NK cells would kill those target cells that have lost, or underexpress, MHC class I molecules. However, a more complex scenario has recently emerged. For example, certain NK cells express insufficient amounts of triggering receptors, and target cells can lack ligands for such receptors. Thus, it appears that the activation of NK cells and their potentially harmful effector functions are under the control of different checkpoints.
引用
收藏
页码:670 / 676
页数:7
相关论文
共 66 条
[1]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
IMMUNOLOGY TODAY, 2000, 21 (09) :447-455
[2]   Activation and function of natural killer cell responses during viral infections [J].
Biron, CA .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (01) :24-34
[3]   Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule [J].
Bottino, C ;
Castriconi, R ;
Pende, D ;
Rivera, P ;
Nanni, M ;
Carnemolla, B ;
Cantoni, C ;
Grassi, J ;
Marcenaro, S ;
Reymond, N ;
Vitale, M ;
Moretta, L ;
Lopez, M ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (04) :557-567
[4]   GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease [J].
Bottino, C ;
Falco, M ;
Parolini, S ;
Marcenaro, E ;
Augugliaro, R ;
Sivori, S ;
Landi, E ;
Biassoni, R ;
Notarangelo, LD ;
Moretta, L ;
Moretta, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) :235-246
[5]   HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C [J].
Braud, VM ;
Allan, DSJ ;
O'Callaghan, CA ;
Söderström, K ;
D'Andrea, A ;
Ogg, GS ;
Lazetic, S ;
Young, NT ;
Bell, JI ;
Phillips, JH ;
Lanier, LL ;
McMichael, AJ .
NATURE, 1998, 391 (6669) :795-799
[6]  
Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO
[7]  
2-L
[8]   Identification of 41g-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis [J].
Castriconi, R ;
Dondero, A ;
Augugliaro, R ;
Cantoni, C ;
Carnemolla, B ;
Sementa, AR ;
Negri, F ;
Conte, R ;
Corrias, MV ;
Moretta, L ;
Moretta, A ;
Bottino, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12640-12645
[9]   Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors:: Consequences for the NK-mediated killing of dendritic cells [J].
Castriconi, R ;
Cantoni, C ;
Della Chiesa, M ;
Vitale, M ;
Marcenaro, E ;
Conte, R ;
Biassoni, R ;
Bottino, C ;
Moretta, L ;
Moretta, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :4120-4125
[10]   INVOLVEMENT OF HLA CLASS-I ALLELES IN NATURAL-KILLER (NK) CELL-SPECIFIC FUNCTIONS - EXPRESSION OF HLA-CW3 CONFERS SELECTIVE PROTECTION FROM LYSIS BY ALLOREACTIVE NK CLONES DISPLAYING A DEFINED SPECIFICITY (SPECIFICITY-2) [J].
CICCONE, E ;
PENDE, D ;
VIALE, O ;
THAN, A ;
DIDONATO, C ;
ORENGO, AM ;
BIASSONI, R ;
VERDIANI, S ;
AMOROSO, A ;
MORETTA, A ;
MORETTA, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :963-971